Holly Mansell, University of Manitoba

Research

Cannabinoids Comparative Effectiveness Drug Resistant Epilepsy Epilepsy Randomized Controlled Trials

Latest funding

A triple-blind, placebo-controlled, randomized clinical trial of CANnabinoids for Drug Resistant Epilepsy (CAN-DRE) in adults and children
CIHR · 2023 · Principal investigator
$749,700

A triple-blind, placebo-controlled, randomized clinical trial of CANnabinoids for Drug Resistant Epilepsy (CAN-DRE) in adults and children

Principal investigatorCIHR2023Project Grant

Principal investigators: Kelly, Lauren; Alcorn, Mary-Jane; Burnham, W. M; Huntsman, Richard J; Jacobs-LeVan, Julia A; Lacaze-Masmonteil, Thierry; Mansell, Holly; McAndrews, Mary Pat; Reid, Aylin Y

Keywords: Cannabinoids; Comparative Effectiveness; Drug Resistant Epilepsy; Epilepsy; Randomized Controlled Trials

$749,700

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Cannabinoids Dear Professor Mansell, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on cannabinoids connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "A triple-blind, placebo-controlled, randomized clinical trial of CANnabinoids for Drug Resistant Epilepsy (CAN-DRE) in adults and children" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]